Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 855-862

  Aandahl, Einar Martin ^a   Aukrust, Pål ^a,b   Skålhegg, Bjørn S ^a   Müller, Fredrik ^a,b   Frøland, Stig S ^a,b   Hansson, Vidar ^a   Taskén, Kjetil ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

AIDS; cAMP; PKA; Rp 8 Br cAMPS

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIDANOSINE; LAMIVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOMODULATION; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031748984     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.10.855     Document Type: Article

References (25)

1. Kammer, G. M. (1988) The adenylate cyclase-cAMP-prbtein kinase A pathway and regulation of the immune response. Immunol.Today 9, 222-229
2. Skålhegg, B. S., Landmark, B. F., Døskeland, S. O., Hansson, V., Lea, T., and Jahnsen, T. (1992) Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′,5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267, 15707-15714
3. Skålhegg, B. S., Taskén, K., Hansson, V., Huitfeldt, H. S., Jahnsen, T., and Lea, T. (1994) Location of cAMP-dependent protein kinase type I with the TCR/CD3 complex. Science 263, 84-87
4. Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P., and Fahey, J. L. (1993) Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 90, 6676-6680
5. Haraguchi, S., Good, R. A., and Day, N. K. (1995) Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16, 595-603
6. Nokta, M. A., and Pollard, R. B. (1992) Human immunodeficiency virus replication: modulation by cellular levels of cAMP. AIDS Res. Hum. Retroviruses 8, 1255-1261
7. Center for Disease Control and Prevention. (1992) 1993: Revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Wkly. Rep. 41, 1
8. Taskén, K., Andersson, K. B., Skålhegg, B. S., Taskén, K. A., Hansson, V., Jahnsen, T., and Blomhoff, H. K. (1993) Reciprocal regulation of mRNA and protein for subunits of cAMP-dependent protein kinase (RIα and Cα) by cAMP in a neoplastic B cell line (Reh). J. Biol. Chem. 268, 23483-23489
9. Taskén, K., Skålhegg, B. S., Solberg, R., Andersson, K. B., Taylor, S. S., Lea, T., Blomhoff, H. K., Jahnsen, T., and Hansson, V. (1993) Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation RIα-RIβ heterodimeric complexes. J. Biol. Chem. 268, 21276-21283
10. Gjertsen, B. T., Mellgren, G., Otten, A., Maronde, E., Genieser, H. G., Jastorff, B., Vintermyr, O. K., McKnight, G. S., and Døskeland, S. O. (1995) Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. J. Biol. Chem. 270, 20599-20607
11. Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron. J. J. J., Feinberg, J. E., Balfour, H. H. J., Deyton, L. R., Chodakewitz, J. A., and Fischl, M. A. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337, 725-733
12. Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., and Chodakewitz, J. A. (1997) Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734-739.
13. Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., and Shearer, G. M. (1993) Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262., 1721-1724.
14. Landay, A. L., Clerici, M., Hashemi, F., Kassler, H., Berzofsky, J. A., and Shearer, G. M. (1996) In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of initerleukin (IL)-12 and anti-IL-10. J.Infect. Dis. 173, 1083-1091.
15. Laxminarayana, D., Berrada, A., and Kammer, G. M. (1993) Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest. 92, 2207-2214
16. Laxminarayana, D., and Kammer, G. M. (1996) Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation. J. Immunol. 156, 497-506
17. 2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Eur. J. Immunol. 26, 1200-1296
18. Torgersen, K. M., Vaage, J. T., Levy, F. O., Hansson, V., Rolstad, B., and Taskén, K. (1997) Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J. Biol. Chem. 272, 5495-5500
19. Ledbetter, J. A., Parsons, M., Martin, P. J., Hansen, J. A., Rabinovitch, P. S., and June, C. H. (1986) Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J. Immunol. 137, 3299-3305
20. Kammer, G. M., Boehm, C. A., Rudolph, S. A., and Schultz, L. A. (1988) Mobility of the human T lymphocyte surface molecules CDS, CD4, and CD8, regulation by a cAMP-dependent pathway. Proc. Natl. Acad. Sci. USA 85, 792-796
21. Kammer, G. M., Khan, I. U., and Malemud, C. J. (1994) Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest. 94, 422-430
22. Dayal, A. K., and Kammer, G. M. (1996) The T cell enigma in lupus [Review]. Arthritis Rheum. 39, 23-33
23. Hofmann, B., Nishanian, P., Nguyen, T., Liu, M., and Fahey, J. L. (1993) Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosinc analogues. AIDS 7, 659-664
24. Pantaleo, G. (1997) How immune-based interventions can change HIV therapy. Nat. Med. 3, 483-486
25. Condra., H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D., J., Quintero, J. C., Rhodes, A., Robbins, H. L., Roth, E., and Shivaprakash, M. (1995) In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (London) 374, 569-571